The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Soligenix (NASDAQ: SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell ly ...

Press release Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

Special Report: Lumos Diagnostics has passed a major milestone in a US CLIA waiver study for its rapid point-of-care diagnostic FebriDx designed to differentiate between bacterial and non-bacterial ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The Global Single-use Assemblies Market valued at $2.25 billion (2021) is set to witness a healthy growth rate of 22% by 2026. Key advantages of ready-to-use single-use assemblies, favorable funding ...